Companies · Other Health Care
Miami · Other Health Care
Diligence memoA one-page analyst read on Med-Tek LLC — recommendation, valuation, rhythm, risks.→Med-Tek LLC looks under-valued against its niche peers and is dormant on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.
Med-Tek LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
Med-Tek LLC is one of 5376 Other Health Care companies tracked from Miami. By capital raised it ranks in the upper tier (ahead of 80% of sector peers), and in the long tail by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 33%.
Round size and date are reported; the stage label is inferred from round size (latest is Series A — a $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.
Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 80% of sector peers (real $). Modeled value above 36% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #174 of 187.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Imagine Health, Inc. | Series A | $15.0M | $302.7M | 2.50× |
| Inova Labs, Inc. | Series A | $32.6M | $302.7M | 2.50× |
| Spruce Health, Inc. | Series A | $15.0M | $302.7M | 2.50× |
| Cephea Valve Technologies, Inc. | Series A | $21.2M | $296.8M | 2.46× |
| ClarVista Medical, Inc. | Series A | $14.5M | $293.0M | 2.42× |
| Minimally Invasive Devices Inc. | Series A | $43.3M | $284.9M | 2.36× |
| Osprey Medical Inc. | Series A | $14.0M | $282.5M | 2.34× |
| IGeneX Group, LLC | Series A | $13.5M | $273.4M | 2.26× |
| Urohsd, Llc | Series A | $13.2M | $266.9M | 2.21× |
| Secure EDI Holdings, LLC | Series A | $28.3M | $263.5M | 2.18× |
| Sterling Healthcare Holdings, Llc | Series A | $13.4M | $259.1M | 2.14× |
| Wallick Senior Housing Holdings, LLC | Series A | $12.8M | $259.1M | 2.14× |
| Med-Tek LLC this company | Series A | $14.7M | $11.1M | 0.09× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Series A | $6.6M | 2012-05-18 | $30.1M | $133.6M | 90% |
| Series A | $6.0M | 2014-05-28 | $27.3M | $121.1M | 90% |
| Series A | $1.5M | 2014-07-31 | $6.8M | $30.3M | 90% |
| Series A | $550K | 2015-02-28 | $2.5M | $11.1M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| EITAN MACHOVER | — | 3 other | 2014-05 |
| David A. Schwedel | — | 2 other | 2012-05 |
| Frank J. Del Rio | — | 1 other | 2012-05 |
| Dale Schwieger | — | — | 2014-05 |
| Eitan J. Machover | — | — | 2012-05 |
| Kerwin Williams | — | — | 2014-05 |
| Michael J. Cusumano | — | — | 2012-05 |
| Stefano B. Rocca | — | — | 2012-05 |
| Thomas B. Bongard | — | — | 2012-05 |
| Tom B. Leamon | — | — | 2012-05 |
Med-Tek LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| WellSense, Inc. | Other Health Care | Series A | $31.8M | $30.9M | network1 shared operator · same sector · same stage |
| EnduraCare Acute Care Services, LLC | Other Health Care | Series A | $14.6M | $10.1M | same sector · same stage |
| Crio Inc. | Other Health Care | Series A | $14.9M | $12.8M | same sector · same stage |
| Cardica Inc | Other Health Care | Series A | $13.8M | $12.1M | same sector · same stage |
| PolyRemedy Inc | Other Health Care | Series A | $13.7M | $10.9M | same sector · same stage |
| Perfusio Corp. | Other Health Care | Series A | $16.4M | $9.3M | same sector · same stage |
| Wellbe Inc. | Other Health Care | Series A | $12.2M | $10.6M | same sector · same stage |
| Scyfix Llc | Other Health Care | Series A | $11.4M | $10.1M | same sector · same stage |
See where Med-Tek LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Med-Tek LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.